A retrospective analysis of low-field strength magnetic resonance imaging and the management of patients with rheumatoid arthritis

References

• Lindqvist E, Jonsson K, Saxne T, Eberhardt K. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis 2003;62:611–6
   PubMed Web of Science ®Google Scholar
• Genta MS, Kardes H, Gabay C. Clinical evaluation of a cohort of patients with rheumatoid arthritis treated with anti-TNF-alpha in the community. Joint Bone Spine 2006;73:51–6
   Google Scholar
• Gonzalez-Juanatey C, Llorca J, Sanchez-Andrade A, et al. Short-term adalimumab therapy improves endothelial function in patients with rheumatoid arthritis refractory to infliximab. Clin Exp Rheumatol 2006;24:309–12
   Google Scholar
• Litinsky I, Paran D, Levartovsky D, et al. The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis. Cytokine 2006;33:106–10
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24
   PubMed Web of Science ®Google Scholar
• Wolfe F, Cathey MA, Roberts FK. The latex test revisited. Rheumatoid factor testing in 8287 rheumatic disease patients. Arthritis Rheum 1991;34: 951–60
   Google Scholar
• Amos RS, Constable TJ, Crockson RA, et al. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J 1977;1:195–7
   PubMed Web of Science ®Google Scholar
• Plant MJ, Williams AL, O’Sullivan MM, et al. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1473–7
   Google Scholar
• Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380–6
   PubMed Web of Science ®Google Scholar
• Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741–9
   Google Scholar
• Forslind K, Ahlmen M, Eberhardt K, et al. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004;63:1090–5
   PubMed Web of Science ®Google Scholar
• Kastbom A, Strandberg G, Lindroos A, Skogh T. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 2004;63:1085–9
   PubMed Web of Science ®Google Scholar
• Lindqvist E, Eberhardt K, Bendtzen K, et al. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196–201
   PubMed Web of Science ®Google Scholar
• Vallbracht I, Rieber J, Oppermann M, et al. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 2004;63:1079–84
   PubMed Web of Science ®Google Scholar
• Hurst S, Kallan MJ, Wolfe FJ, et al. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects. J Rheumatol 2002;29:1639–45
   PubMed Web of Science ®Google Scholar
• Tsakonas E, Fitzgerald AA, Fitzcharles MA, et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year follow-up on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 2000;27:623–9
   PubMed Web of Science ®Google Scholar
• Munro R, Hampson R, McEntegart A, et al. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann Rheum Dis 1998;57:88–93
   PubMed Web of Science ®Google Scholar
• Landewe RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347–56
   PubMed Web of Science ®Google Scholar
• Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. New Engl J Med 2000;343:1586–93
   PubMed Web of Science ®Google Scholar
• Klareskog L, van der Heijde D, de Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675–81
   PubMed Web of Science ®Google Scholar
• Breedveld FC, Emery P, Keystone E, et al. Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 2004;63:149–55
   PubMed Web of Science ®Google Scholar
• St Clair EW, van der Heijde DM, Smolen JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;50:3432–43
   PubMed Web of Science ®Google Scholar
• Bykerk VP, Keystone EC. What are the goals and principles of management in the early treatment of rheumatoid arthritis? Best Pract Res Clin Rheumatol 2005;19:147–61
   PubMed Web of Science ®Google Scholar
• Emery P, Breedveld FC, Dougados M, et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290–7
   PubMed Web of Science ®Google Scholar
• Issa SN, Ruderman EM. Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destruction. Postgrad Med 2004;116:14–6, 21–4
   Google Scholar
• Scott DL. Pursuit of optimal outcomes in rheumatoid arthritis. Pharmacoeconomics 2004;22:13–26
   PubMed Web of Science ®Google Scholar
• Breedveld FC, Han C, Bala M, et al. Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:52–5
   PubMed Web of Science ®Google Scholar
• Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. New Engl J Med 2000;343:1594–602
   PubMed Web of Science ®Google Scholar
• Scott DL. Radiological progression in established rheumatoid arthritis. J Rheumatol Suppl 2004;69:55–65
   PubMedGoogle Scholar
• Strand V, Sharp JT. Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned? Arthritis Rheum 2003;48:21–34
   PubMed Web of Science ®Google Scholar
• McQueen FM, Benton N, Perry D, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1814–27
   PubMed Web of Science ®Google Scholar
• Benton N, Stewart N, Crabbe J, et al. MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years. Ann Rheum Dis 2004;63:555–61
   PubMed Web of Science ®Google Scholar
• Ostergaard M, Hansen M, Stoltenberg M, et al. New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. Arthritis Rheum 2003;48:2128–31
   PubMed Web of Science ®Google Scholar
• Nijenhuis S, Zendman AJ, Vossenaar ER, et al. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta 2004;350:17–34
   PubMed Web of Science ®Google Scholar
• Hosmer DW, Lemeshow S. Applied logistic regression. New York (NY): John Wiley & Sons, Inc.; 1989
   Google Scholar
• van der Heijde D. Impact of imaging in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17:783–90
   PubMed Web of Science ®Google Scholar
• Devauchelle-Pensec V, Saraux A, Alapetite S, et al. Diagnostic value of radiographs of the hands and feet in early rheumatoid arthritis. Joint Bone Spine 2002;69:434–41
   Google Scholar
• Peterfy CG. Is there a role for extremity magnetic resonance imaging in routine clinical management of rheumatoid arthritis? J Rheumatol 2004;31:640–4
   PubMed Web of Science ®Google Scholar
• Crues JV, Shellock FG, Dardashti S, et al. Identification of wrist and metacarpophalangeal joint erosions using a portable magnetic resonance imaging system compared to conventional radiographs. J Rheumatol 2004;31:676–85
   PubMed Web of Science ®Google Scholar
• Pincus T, Sokka T. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa? Ann Rheum Dis 2004;63\(Suppl 2):ii32–ii9
   Google Scholar
• Sokka T, Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology Criteria for Remission. J Rheumatol 2003;30:1138–46
   PubMed Web of Science ®Google Scholar